Adenovirus vector vaccines.
Drug Delivery System
; 37(5):421-428, 2022.
Article
in Japanese
| EMBASE | ID: covidwho-2272410
ABSTRACT
Recently, importance of vaccines for treatment and prevention of emerging and re-emerging infectious diseases has been re-recognized. A replication-incompetent adenovirus(Ad)vector DDS vaccine expressing virus antigen proteins is one of the most advanced platforms as a novel vaccine because an Ad vector vaccine can be rapidly applicable to pandemic. In this review, we describe the basic properties of an Ad vector for vaccine, in addition to the summary of the development of an Ad vector vaccine for emerging and re-emerging infectious diseases, including Coronavirus disease 2019(COVID-19), worldwide.Copyright © 2022, Japan Society of Drug Delivery System. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
Japanese
Journal:
Drug Delivery System
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS